Appointment

Date: June 26, 2026 1. The Manager- Listing National Stock Exchange of India Limited (Scrip Symbol: NAUKRI) 2. The Manager- Listing BSE Limited (Scrip Code: 532777) Dear Sir/Madam, Subject: Outcome of the Board Meeting - June 26, 2026 Ref: Intimation pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Pursuant to Regulation 30 read with Schedule III of the Listing Regulations, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e. Friday, June 26, 2026, has, inter alia, considered and approved the following: A. Appointment of Mr. Himanshu Agarwal (DIN: 06672915) as Chief Financial Officer (Key Managerial Personnel), and Additional Director of the Company, to be designated as Whole-time Director and Chief Financial Officer of the Company: The Board on the recommendation of Nomination & Remuneration Committee and Audit Committee has approved the appointment of Mr. Himanshu Agarwal (DIN: 06672915) as the Chief Financial Officer (Key Managerial Personnel), and Additional Director of the Company, to be designated as Whole-time Director and Chief Financial Officer of the Company, w.e.f. September 17, 2026. The said appointment of Mr. Agarwal as the Whole-time Director of the Company shall be for a term of 5 (five) consecutive years i.e. w.e.f. September 17, 2026 to September 16, 2031, subject to the approval of shareholders and other applicable statutory approvals, if any. The Company shall intimate the stock exchanges upon Mr. Agarwal assuming the office. Further, Mr. Agarwal is not related to any of the Directors of the Company and is not debarred from holding the office of Director by virtue of any SEBI order or order of any other authority and therefore is not disqualified to be appointed as Director. Furthermore, the details as required in terms of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 in relation to the above referred item are enclosed as Annexure A to this intimation. B. Re-constitution of the Committees of the Board of Directors: The Board of Directors, based on the recommendation of the Nomination & Remuneration Committee, approved the re-constitution of certain Committees of the Board of Directors with effect from June 27, 2026, to facilitate a smooth transition and ensure continuity in the functioning of the Committees in light of the completion of the current term of Mr. Ashish Gupta as an Independent Director of the Company on July 20, 2026. INFO EDGE (IN DIA) LIMITED Corporate Office: B-8, Sector - 132, Noida - 201304, Tel.: 0120 - 3082000, Fax: 0120-3082095 Email: investors@naukri.com URL: http://www.infoedge.in CIN: L74899DL1995PLC068021 Regd. Office: Ground Floor, 12A, 94, Meghdoot, Nehru Place, New Delhi-110019 Audit Committee: Ms. Radha Rajappa, Additional Director (Independent Category), has been inducted as a Member of the Audit Committee with effect from June 27, 2026. The composition of the Audit Committee shall be as under: S.No. Name of the Member Category Position in the Committee 1. Mr. Sanjiv Sachar Independent Director Chairman 2. Mr. Ashish Gupta Independent Director Member 3. Ms. Geeta Mathur Independent Director Member 4. Ms. Radha Rajappa Independent Director Member Nomination & Remuneration Committee: Mr. Rajesh Magow, Additional Director (Independent Category), has been inducted as a Member of the Nomination & Remuneration Committee with effect from June 27, 2026. To ensure an orderly transition in the leadership of the Committee, he shall assume the position of Chairman of the Committee with effect from July 21, 2026. The composition of the Nomination & Remuneration Committee shall be as under: S.No Name of Member Category Position in the Committee 1. Mr. Ashish Gupta Independent Director Chairman & Member till July 20, 2026 2. Mr. Kapil Kapoor Non-Executive Director Member 3. Mr. Sanjiv Sachar Independent Director Member 4. Mr. Rajesh Magow Independent Director Member with effect from June 27, 2026 and Chairman with effect from July 21, 2026 The exchanges are also informed that the Board Meeting commenced at 07:34 p.m. and concluded at 07:55 p.m. This intimation is also being uploaded on Company’s website and can be accessed at www.infoedge.in. We request you to kindly take the above on record. Thanking You, Yours faithfully, For Info Edge (India) Limited Jaya Bhatia Company Secretary & Compliance Officer Encl.: A/a INFO EDGE (IN DIA) LIMITED Corporate Office: B-8, Sector - 132, Noida - 201304, Tel.: 0120 - 3082000, Fax: 0120-3082095 Email: investors@naukri.com URL: http://www.infoedge.in CIN: L74899DL1995PLC068021 Regd. Office: Ground Floor, 12A, 94, Meghdoot, Nehru Place, New Delhi-110019 Annexure A Disclosure of information pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Appointment of Mr. Himanshu Agarwal (DIN: 06672915) as Chief Financial Officer (Key Managerial Personnel), and Additional Director of the Company, to be designated as Whole-time Director and Chief Financial Officer of the Company: S.No. Particulars Mr. Himanshu Agarwal 1. Reason for change viz. Appointment of Mr. Himanshu Agarwal (DIN: 06672915) as appointment, re- Chief Financial Officer (Key Managerial Personnel), and appointment, resignation, Additional Director of the Company, to be designated as Whole- removal, death or time Director and Chief Financial Officer of the Company otherwise 2. Date of appointment/re- Mr. Himanshu Agarwal will be appointed as Chief Financial appointment/cessation (as Officer and Additional Director, as disclosed in point 1 above, applicable) w.e.f. September 17, 2026. Term of Appointment – The appointment of Mr. Himanshu Term of appointment/re- Agarwal as Whole-time Director shall be for a term of 5 (five) appointment consecutive years, i.e. w.e.f. September 17, 2026 to September 16, 2031, subject to the approval of shareholders and other applicable statutory approvals, if any. The Company shall intimate the stock exchanges upon Mr. Agarwal assuming the office. 3. Brief Profile (in case of Mr. Himanshu Agarwal has over three decades of experience in appointment) finance leadership, corporate governance, mergers and acquisitions, and business transformation across listed organisations in India and internationally. Mr. Agarwal has held senior finance leadership positions at ICI India Limited, AstraZeneca Pharma India Limited, AkzoNobel India Limited (where he also served as Whole Time Director), Huhtamaki Oyj (Flexible Packaging Division), Bennett, Coleman and Co. Limited (Times Group), and is currently serving as Whole Time Director and Chief Financial Officer of Cohance Lifesciences Limited. Mr. Agarwal has been recognised for his contributions to the finance profession, including being conferred the Best CFO Award by the Institute of Chartered Accountants of India and being recognised among the Top 100 India CFOs by the CFO Institute. He is a qualified Chartered Accountant, Company Secretary and Cost and Management Accountant. 4. Disclosure of relationships Mr. Himanshu Agarwal is not related to any Director(s) of the between Directors (in case Company. of appointment of a director) INFO EDGE (IN DIA) LIMITED Corporate Office: B-8, Sector - 132, Noida - 201304, Tel.: 0120 - 3082000, Fax: 0120-3082095 Email: investors@naukri.com URL: http://www.infoedge.in CIN: L74899DL1995PLC068021 Regd. Office: Ground Floor, 12A, 94, Meghdoot, Nehru Place, New Delhi-110019